API drugmaker Alembic Pharmaceuticals is diving into the oncology arena by opening an anticancer manufacturing facility at Panelav, Halol, in Gujarat.
The company, best known for manufacturing anti-infective, analgesic and cough and cold therapies, said the facility will manufacture 60 million tablets and capsules and about 20 million vials of liquid injectable and lyophilized concentrates.
Chirayu Amin, chairman of Alembic, said the company expects to export oncology products to the U.S., Middle East, North Africa, Australia and South Africa. The facility boasts the latest manufacturing equipment from Germany, Belgium, the U.K., and China, he said.
Alembic managing director Pranav Amin said the company is looking to invest about $23 million as part of its expansion plan over the next three years, the Economic Times Healthworld reported.